ARTICLE | Clinical News
Inclisiran: Additional Ph II ORION-1 data
November 18, 2016 6:29 PM UTC
Additional data from the double-blind, international Phase II ORION-1 trial in 497 patients with atherosclerotic cardiovascular disease or atherosclerotic cardiovascular disease-risk equivalents and e...
BCIQ Target Profiles